Public Event Detail
State Street Corp Has $5.29 Billion Holdings in Bristol Myers Squibb Company $BMY
Public historical observation from the Merrowstone archive. This page shows event-level context only. Accepted assertions, evidence lineage, and relationship intelligence remain part of the premium research layer.
Historical observations only. No forecasts, recommendations, buy/sell ratings, or portfolio advice.
2026-06-14JPMJPMorgan ChaseAlpha Vantage Newsearnings
Event summary
State Street Corp significantly increased its holdings in Bristol Myers Squibb (NYSE:BMY) by 1.4% in the fourth quarter, reaching approximately 97.98 million shares valued at $5.29 billion. Bristol Myers Squibb reported strong quarterly results, beating EPS and revenue expectations, and provided optimistic guidance for FY2026. Despite a mixed Wall Street sentiment with an average "Hold" rating, the company shows pipeline progress and growth in newer drugs, though facing some competitive pressure.
Attached public signals
Observed outcomes
7d returnPending
30d returnPending
90d returnPending
Relative 90d returnPending